Literature DB >> 16239297

Changes in tight junctional resistance of the cervical epithelium are associated with modulation of content and phosphorylation of occludin 65-kilodalton and 50-kilodalton forms.

Ling Zhu1, Xin Li, Robin Zeng, George I Gorodeski.   

Abstract

Treatment of human cervical epithelial CaSki cells with ATP or with the diacylglyceride sn-1,2-dioctanoyl diglyceride (diC8) induced a staurosporine-sensitive transient increase, followed by a late decrease, in tight-junctional resistance (R(TJ)). CaSki cells express two immunoreactive forms of occludin, 65 and 50 kDa. Treatments with ATP and diC8 decreased the density of the 65-kDa form and increased the density of the 50-kDa form. ATP also decreased threonine phosphorylation of the 65-kDa form and increased threonine phosphorylation of the 50-kDa form and tyrosine phosphorylation of the 65- and 50-kDa forms. Staurosporine decreased acutely threonine and tyrosine phosphorylation of the two isoforms and in cells pretreated with staurosporine ATP increased acutely the density of the 65-kDa form and threonine phosphorylation of the 65-kDa form. Treatment with N-acetyl-leucinyl-leucinyl-norleucinal increased the densities of the 65- and 50-kDa forms. Pretreatment with N-acetyl-leucinyl-leucinyl-norleucinal attenuated the late decreases in R(TJ) induced by ATP and diC8 and the decrease in the 65-kDa and increase in the 50-kDa forms induced by ATP. Correlation analyses showed that high levels of R(TJ) correlated with the 65-kDa form, whereas low levels of R(TJ) correlated negatively with the 65-kDa form and positively with the 50-kDa form. The results suggest that in CaSki cells 1) occludin determines gating of the tight junctions, 2) changes in occludin phosphorylation status and composition regulate the R(TJ), 3) protein kinase-C-mediated, threonine dephosphorylation of the 65-kDa occludin form increases the resistance of assembled tight junctions, 4) the early stage of tight junction disassembly involves calpain-mediated breakdown of occludin 65-kDa form to the 50-kDa form, and 5) increased levels of the 50-kDa form interfere with occludin gating of the tight junctions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239297      PMCID: PMC2409057          DOI: 10.1210/en.2005-0916

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  40 in total

1.  Bryostatin-1 enhances barrier function in T84 epithelia through PKC-dependent regulation of tight junction proteins.

Authors:  James Yoo; Anthony Nichols; Joshua Mammen; Isabel Calvo; Jaekyung C Song; Roger T Worrell; Karl Matlin; Jeffrey B Matthews
Journal:  Am J Physiol Cell Physiol       Date:  2003-03-26       Impact factor: 4.249

2.  Role of protein tyrosine phosphorylation in acetaldehyde-induced disruption of epithelial tight junctions.

Authors:  K J Atkinson; R K Rao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-06       Impact factor: 4.052

3.  Shear stress regulates occludin content and phosphorylation.

Authors:  L DeMaio; Y S Chang; T W Gardner; J M Tarbell; D A Antonetti
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-07       Impact factor: 4.733

4.  Regulation of transcervical permeability by two distinct P2 purinergic receptor mechanisms.

Authors:  George I Gorodeski
Journal:  Am J Physiol Cell Physiol       Date:  2002-01       Impact factor: 4.249

5.  Expression, regulation, and function of P2X(4) purinergic receptor in human cervical epithelial cells.

Authors:  George I Gorodeski
Journal:  Am J Physiol Cell Physiol       Date:  2002-01       Impact factor: 4.249

6.  Protein kinase C regulates the phosphorylation and cellular localization of occludin.

Authors:  A Y Andreeva; E Krause; E C Müller; I E Blasig; D I Utepbergenov
Journal:  J Biol Chem       Date:  2001-08-13       Impact factor: 5.157

7.  Tyrosine phosphorylation of occludin attenuates its interactions with ZO-1, ZO-2, and ZO-3.

Authors:  G Kale; A P Naren; P Sheth; R K Rao
Journal:  Biochem Biophys Res Commun       Date:  2003-03-07       Impact factor: 3.575

Review 8.  Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms.

Authors:  Adrian M Senderowicz
Journal:  Cancer Chemother Pharmacol       Date:  2003-06-18       Impact factor: 3.333

Review 9.  Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2.

Authors:  Louise N Johnson; Erika De Moliner; Nick R Brown; Haiwei Song; David Barford; Jane A Endicott; Martin E M Noble
Journal:  Pharmacol Ther       Date:  2002 Feb-Mar       Impact factor: 12.310

10.  Occludin TM4(-): an isoform of the tight junction protein present in primates lacking the fourth transmembrane domain.

Authors:  M Reza Ghassemifar; Bhavwanti Sheth; Tom Papenbrock; Henry J Leese; Franchesca D Houghton; Tom P Fleming
Journal:  J Cell Sci       Date:  2002-08-01       Impact factor: 5.285

View more
  15 in total

1.  Estrogen regulates epithelial cell deformability by modulation of cortical actomyosin through phosphorylation of nonmuscle myosin heavy-chain II-B filaments.

Authors:  Xin Li; Lingying Zhou; George I Gorodeski
Journal:  Endocrinology       Date:  2006-08-10       Impact factor: 4.736

Review 2.  Purinergic signalling in the reproductive system in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-23       Impact factor: 3.765

Review 3.  Ca2+ signaling in airway epithelial cells facilitates leukocyte recruitment and transepithelial migration.

Authors:  Jarin Chun; Alice Prince
Journal:  J Leukoc Biol       Date:  2009-07-15       Impact factor: 4.962

4.  Occludin is regulated by epidermal growth factor receptor activation in brain endothelial cells and brains of mice with acute liver failure.

Authors:  Feng Chen; Tomohide Hori; Norifumi Ohashi; Ann-Marie Baine; Christopher B Eckman; Justin H Nguyen
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

5.  Estrogen modulation of MgATPase activity of nonmuscle myosin-II-B filaments.

Authors:  George I Gorodeski
Journal:  Endocrinology       Date:  2006-10-05       Impact factor: 4.736

6.  The P2X7 receptor: a novel biomarker of uterine epithelial cancers.

Authors:  Xin Li; Lingying Zhou; Ying-Hong Feng; Fadi W Abdul-Karim; George I Gorodeski
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-10       Impact factor: 4.254

7.  Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occludin.

Authors:  George I Gorodeski
Journal:  Endocrinology       Date:  2006-10-12       Impact factor: 4.736

Review 8.  Occludin: one protein, many forms.

Authors:  Philip M Cummins
Journal:  Mol Cell Biol       Date:  2011-11-14       Impact factor: 4.272

9.  Estrogen modulation of epithelial permeability in cervical-vaginal cells of premenopausal and postmenopausal women.

Authors:  George I Gorodeski
Journal:  Menopause       Date:  2007 Nov-Dec       Impact factor: 2.953

10.  The bacterial effectors EspG and EspG2 induce a destructive calpain activity that is kept in check by the co-delivered Tir effector.

Authors:  Paul Dean; Sabrina Mühlen; Sabine Quitard; Brendan Kenny
Journal:  Cell Microbiol       Date:  2010-03-25       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.